REGENXBIO
RGNX
$16.19
Share price
0.81%
Change (1 day)
-13.19%
Change (1 year)
Categories
REGENXBIO (RGNX) - P/B ratio
P/B ratio as of April 2024 : 2.55
According to REGENXBIO's latest financial reports the company has a price-to-book ratio of 2.55.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
REGENXBIO - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.53 | 33.16% |
| 2022-12-31 | 1.90 | 3.95% |
| 2021-12-31 | 1.83 | -59.34% |
| 2020-12-31 | 4.50 | 33.67% |
| 2019-12-31 | 3.37 | 13.05% |
| 2018-12-31 | 2.98 | -47.37% |
| 2017-12-31 | 5.66 | 86.33% |
| 2016-12-31 | 3.04 | 50.72% |
| 2015-12-31 | 2.01 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -4.79% | 🇺🇸 USA |